Safety of Intraoperative Use of Muscle Relaxants and Their Reversal Agent Neostigmine
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators evaluate the assumption that postoperative residual curarization is associated with impaired gas exchange upon post anesthesia care unit arrival and longer hospital length of stay. Additionally, the investigators also evaluate the assumption the use of neostigmine reversal of residual neuromuscular block is associated with an increased incidence of postoperative pulmonary complications and intensive care unit admission.
| Condition |
|---|
|
Postoperative Residual Curarization Impaired Gas Exchange Atelectasis Hospital Length of Stay Postoperative ICU Admission |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Consequences on Respiratory Morbidity and Health-care Utilization of Partial Paralysis Upon Admission to the Postanesthesia Care. |
- Impaired gas exchange [ Time Frame: Within 10 min. upon PACU arrival ] [ Designated as safety issue: Yes ]Gas exchange is assessed by a ratio of pulse oxymetry oxygen saturation relative to fraction of inspired oxygen. Oxygen saturation at PACU admission is defined as the first oxygen saturation value written by an independent nurse in patients' clinical PACU note.
- Hospital Length of Stay [ Time Frame: within 100 days after surgery ] [ Designated as safety issue: No ]Hospital length of stay is defined as the length from the day of the surgery to hospital discharge.
- Incidence of postoperative atelectasis [ Time Frame: Within one month after surgery ] [ Designated as safety issue: Yes ]Diagnosis of atelectasis will be retrieved from the hospital billing data.
- Incidence of unplanned postoperative intensive care unit admission [ Time Frame: Within one week after surgery ] [ Designated as safety issue: Yes ]Incidence of unplanned postoperative intensive care unit admission due to respiratory failure, pulmonary edema and arrhythmia.
| Estimated Enrollment: | 3000 |
| Study Start Date: | April 2011 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
non-depolarizing muscle relaxants
The investigators enroll patients arriving in the postanesthesia care unit after receiving non-depolarizing neuromuscular blocking agents as part of their surgical anesthesia.
|
Detailed Description:
The investigators' laboratory has recently identified the intraoperative use of intermediate-acting non-depolarizing neuromuscular blocking agents and neostigmine reversal of neuromuscular blockade as independent risk factors for severe postoperative respiratory complications. Additionally, the investigators found that postoperative residual curarization (PORC), defined as a train-of-four ratio less than 0.90 upon postanesthesia care unit (PACU) arrival, is associated with an increased PACU length of stay.
To examine the mechanisms contributing to the association of neuromuscular transmission failure with postoperative respiratory complications, the investigators aim to evaluate in a performance improvement driven initiative to better understand the association between the use of neuromuscular blocking agents and reversal agents with postoperative respiratory complications (see British Medical Journal 2012 Oct 15;345:e6329) if patients presenting with PORC develop subsequently 1) an increased incidence of postoperative impaired gas exchange upon PACU admission and result in 2) an increased hospital length of stay. In addition the investigators evaluated the effects of neostigmine on signs and symptoms of postoperative respiratory dysfunction and an incidence of unplanned postoperative intensive care unit admission.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients given non-depolarizing neuromuscular blocking agents as part of general anesthesia
Inclusion Criteria:
- Each subject has been given non-depolarizing neuromuscular blocking agents as part of general anesthesia.
- Each subject must be at least 18 years of age
Exclusion Criteria:
- The subject is scheduled to be transferred to an intensive care unit after surgery.
Contacts and Locations| United States, Massachusetts | |
| Massachusetts General Hospital | |
| Boston, Massachusetts, United States, 02114 | |
| Principal Investigator: | Matthias Eikermann, MD, PhD | Partners |
More Information
Publications:
| Responsible Party: | Matthias Eikermann, Associate professor, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT01718860 History of Changes |
| Other Study ID Numbers: | 2011P000454, IISP#39443 |
| Study First Received: | October 29, 2012 |
| Last Updated: | May 6, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Massachusetts General Hospital:
|
PORC neostigmine |
Additional relevant MeSH terms:
|
Pulmonary Atelectasis Lung Diseases Respiratory Tract Diseases Neuromuscular Nondepolarizing Agents Neostigmine Neuromuscular Blocking Agents Neuromuscular Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Pharmacologic Actions Cholinesterase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Cholinergic Agents Neurotransmitter Agents Parasympathomimetics Autonomic Agents |
ClinicalTrials.gov processed this record on June 13, 2013